Y 
Yunnan Botanee Bio-Technology Group Co 300957.SZ · CNY
Consumer Staples · Shenzhen · 🇨🇳 China
28.88
-1.74%
Close of 9 Nov 2026, in CNY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in CNY, from our data supplier.
Revenue
CN¥5.36bn
FY2017FY2025
Net income
CN¥505.7m
FY2017FY2025
Free cash flow
CN¥493.6m
FY2017FY2025
Shareholders' equity
CN¥6.16bn
FY2017FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | CN¥5.36bn | CN¥5.74bn | CN¥5.73bn | CN¥5.01bn | CN¥4.02bn | CN¥2.64bn | CN¥1.94bn | CN¥1.24bn | CN¥798.0m |
| Gross profit | CN¥3.99bn | CN¥4.17bn | CN¥4.27bn | CN¥3.75bn | CN¥3.05bn | CN¥2.00bn | CN¥1.55bn | CN¥1.00bn | CN¥644.3m |
| Research and development | CN¥237.4m | CN¥295.2m | CN¥298.8m | CN¥254.7m | CN¥113.2m | CN¥63.4m | CN¥54.1m | CN¥46.0m | CN¥28.9m |
| Operating income | CN¥625.1m | CN¥624.5m | CN¥878.0m | CN¥1.21bn | CN¥1.02bn | CN¥649.7m | CN¥502.1m | CN¥312.7m | CN¥186.1m |
| Net income | CN¥505.7m | CN¥503.1m | CN¥756.8m | CN¥1.05bn | CN¥862.9m | CN¥543.5m | CN¥411.9m | CN¥260.5m | CN¥153.6m |
| Diluted earnings per share | 1.20 | 1.22 | 1.79 | 2.48 | 2.42 | 1.52 | 1.15 | 0.62 | 0.37 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | CN¥8.34bn | CN¥8.30bn | CN¥7.51bn | CN¥6.72bn | CN¥5.81bn | CN¥1.68bn | CN¥1.08bn | CN¥764.0m | CN¥501.8m |
| Cash and short-term investments | — | CN¥4.24bn | CN¥3.33bn | CN¥3.95bn | CN¥2.82bn | CN¥752.0m | CN¥527.2m | CN¥251.1m | CN¥262.9m |
| Total liabilities | CN¥2.04bn | CN¥2.12bn | CN¥1.49bn | CN¥1.12bn | CN¥1.03bn | CN¥481.5m | CN¥322.8m | CN¥313.1m | CN¥239.4m |
| Debt | CN¥207.0m | CN¥754.4m | CN¥171.8m | CN¥50.9m | CN¥76.3m | CN¥53.2m | CN¥15.0m | — | — |
| Shareholders' equity | CN¥6.16bn | CN¥6.05bn | CN¥5.86bn | CN¥5.55bn | CN¥4.76bn | CN¥1.20bn | CN¥756.3m | CN¥445.1m | CN¥254.9m |
| Shares outstanding | 420m | 412m | 422m | 424m | 357m | 357m | 359m | 420m | 420m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | CN¥976.6m | CN¥694.9m | CN¥610.4m | CN¥769.4m | CN¥1.15bn | CN¥431.0m | CN¥514.9m | CN¥102.2m | CN¥202.4m |
| Capital spending | −CN¥483.0m | −CN¥378.4m | −CN¥274.3m | −CN¥353.4m | −CN¥270.7m | −CN¥89.5m | −CN¥61.0m | −CN¥31.6m | −CN¥13.6m |
| Free cash flow | CN¥493.6m | CN¥316.5m | CN¥336.2m | CN¥416.0m | CN¥882.0m | CN¥341.6m | CN¥453.9m | CN¥70.6m | CN¥188.8m |
| Dividends paid | −CN¥265.6m | −CN¥262.5m | −CN¥339.1m | −CN¥55.5m | −CN¥190.6m | −CN¥100.8m | −CN¥190.8m | −CN¥37.4m | −CN¥1.4m |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | CN¥1.47bn | CN¥1.12bn | CN¥1.89bn | CN¥1.09bn | CN¥1.42bn | CN¥948.8m | CN¥1.72bn | CN¥1.21bn |
| Gross profit | CN¥1.11bn | CN¥820.0m | CN¥1.42bn | CN¥772.1m | CN¥1.09bn | CN¥735.0m | CN¥1.21bn | CN¥933.4m |
| Operating income | CN¥224.5m | CN¥110.6m | CN¥334.8m | CN¥5.3m | CN¥255.4m | CN¥49.8m | CN¥150.7m | −CN¥68.6m |
| Net income | CN¥225.8m | CN¥66.0m | CN¥233.8m | CN¥25.2m | CN¥218.3m | CN¥28.3m | CN¥88.3m | −CN¥69.0m |
| Diluted earnings per share | 0.54 | 0.16 | 0.56 | 0.06 | 0.52 | 0.07 | 0.21 | -0.17 |
| Cash from operations | — | — | — | CN¥125.0m | CN¥415.0m | −CN¥54.0m | CN¥688.0m | −CN¥122.0m |
| Capital spending | −CN¥13.0m | −CN¥17.0m | −CN¥43.0m | −CN¥29.0m | −CN¥40.0m | −CN¥369.0m | −CN¥122.0m | −CN¥80.0m |
| Free cash flow | — | — | — | CN¥96.0m | CN¥375.0m | −CN¥423.0m | CN¥566.0m | −CN¥202.0m |
| Total assets | CN¥8.19bn | CN¥8.29bn | CN¥8.34bn | CN¥8.20bn | CN¥7.98bn | CN¥7.62bn | CN¥8.30bn | CN¥7.80bn |
| Cash and short-term investments | — | — | — | CN¥3.94bn | CN¥3.91bn | CN¥3.57bn | CN¥4.24bn | CN¥3.14bn |
| Debt | CN¥232.8m | CN¥207.0m | CN¥207.0m | CN¥676.3m | CN¥694.8m | CN¥482.7m | CN¥636.2m | CN¥567.3m |
| Shareholders' equity | CN¥6.15bn | CN¥6.10bn | CN¥6.16bn | CN¥6.08bn | CN¥6.05bn | CN¥6.08bn | CN¥6.05bn | CN¥5.90bn |
Financial ratios
Data as of 28 Sept 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|
| Gross margin | 74.5% | 72.7% | 74.5% | 74.8% | 75.7% | 75.9% | — |
| Operating margin | 11.7% | 10.9% | 15.3% | 24.2% | 25.3% | 24.6% | — |
| Net margin | 9.4% | 8.8% | 13.2% | 21.0% | 21.5% | 20.6% | — |
| Return on equity | 8.2% | 8.3% | 12.9% | 18.9% | 18.1% | 45.3% | — |
| Return on assets | 6.1% | 6.1% | 10.1% | 15.6% | 14.8% | 32.3% | — |
| Free cash flow yield | 10.7% | 8.0% | 6.5% | 8.2% | 12.3% | 4.5% | — |
| Revenue growth | -6.6% | 0.1% | 14.2% | 24.6% | 52.6% | 35.6% | — |
| Earnings growth | 0.5% | -33.5% | -28.0% | 21.8% | 58.8% | 31.9% | — |
| Current ratio | 3.77x | 4.04x | 4.28x | 5.76x | 5.81x | 3.32x | — |
| Debt to equity | 0.03x | 0.11x | 0.02x | 0.01x | 0.01x | — | 0.02x |
| Equity ratio | 73.8% | 72.9% | 78.1% | 82.6% | 81.8% | 71.2% | — |
| Interest coverage | 34.18x | 33.36x | 134.68x | 203.22x | 242.56x | 385.10x | — |
| R&D as a share of sales | 4.4% | 5.1% | 5.2% | 5.1% | 2.8% | 2.4% | — |
| Buybacks as a share of market value | -1.9% | 2.4% | 0.4% | -18.6% | 0.0% | 0.6% | — |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 2.2% | 15.2% | — |
| Operating income | -19.8% | -0.8% | — |
| Net income | -21.6% | -1.4% | — |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 73.6% | 74.1% | 74.5% | — |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|
| Price to earnings | 32.9 | 35.0 | 38.0 | 60.1 | 79.6 |
| Price to sales | 3.1 | 3.1 | 5.0 | 12.6 | 17.1 |
Dividends and splits
Per share, in the currency the company pays
Paid for 5 years. Last went ex-dividend on 10 Mar 2026.
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Paid in the year | 0.30 | 0.60 | 0.60 | 0.80 | 0.60 | 0.45 |
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.